Lotemax SM - (0.38% ; Gel, Opthalmic)

Generic Name	Loteprednol Etabonate	Innovator	BAUSCH AND LOMB INC
Dosage	0.38% ; Gel, Opthalmic	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	LOTEMAX® SM is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*****	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events